Skip to main content
ChemoMetec logo

ChemoMetec — Investor Relations & Filings

Ticker · CHEMM ISIN · DK0060055861 LEI · 213800533NBKECGONO68 CO Manufacturing
Open in API
Filings indexed 540 across all filing types
Latest filing 2018-05-09 Earnings Release
Country DK Denmark
Listing CO CHEMM

About ChemoMetec

https://chemometec.com

ChemoMetec is a global manufacturer specializing in high-precision automated cell counting and analysis instrumentation. The company develops and produces a range of advanced image cytometers and cell density analyzers, including the NucleoCounter® and XcytoMatic® series. These systems provide consistent, reproducible, and accurate cell count and viability data for a wide range of cell types. Key technologies include fluorescence microscopy, which enables trypan blue-free analysis, and specialized consumables designed to minimize human error. ChemoMetec's instruments are designed for regulated environments, offering software solutions compliant with FDA 21 CFR Part 11 and supporting Good Manufacturing Practice (GMP) workflows. The company serves customers in the biotechnology, pharmaceutical, and academic sectors, with applications in cell and gene therapy, cancer research, and bioprocessing.

Recent filings

Filing Released Lang Actions
Earnings Release 2017
Earnings Release Classification · 100% confidence The document is explicitly titled 'Periodemeddelelse for 3. kvartal 2017/18 (1. januar - 31. marts 2018)' (Period announcement for Q3 2017/18). It provides detailed financial highlights (revenue, EBITDA) and operational updates for a specific interim period (a quarter). This structure perfectly matches the definition of an Interim / Quarterly Report (IR). Although it contains a link to an attached file, the document itself contains substantial financial data and analysis, making it the report content rather than just a simple announcement of publication (RPA). Q3 2017
2018-05-09 Danish
Interim / Quarterly Report 2017
Interim / Quarterly Report Classification · 100% confidence The document is a 'Periodemeddelelse' (Interim Report) for the 3rd quarter of the 2017/18 fiscal year. It contains detailed financial performance data, including revenue, EBITDA, segment breakdowns, and product development updates. It is not a mere announcement of a report, as it provides the actual financial results and analysis for the specified period. Therefore, it fits the definition of an Interim/Quarterly Report (IR). Q3 2017
2018-05-09 English
Transaction in Own Shares 2018
Transaction in Own Shares Classification · 100% confidence The document is titled "Aktietilbagekøb" (Share Buyback) and explicitly states that ChemoMetec A/S has acquired 134,000 of its own shares. This action directly relates to the company managing its own stock holdings, which falls under the category of 'Transaction in Own Shares'. The document is a formal announcement (MEDDELELSE NR. 149) detailing the number of shares bought back and the resulting percentage of treasury stock held (11.72%). This matches the definition for Transaction in Own Shares (POS). The document length is short (1505 chars) and it includes an attachment link, but the core content is the transaction itself, not just an announcement of a report release, making POS a more specific fit than RPA or RNS.
2018-04-24 Danish
Transaction in Own Shares 2018
Transaction in Own Shares Classification · 99% confidence The document is a short announcement (Meddelelse Nr. 149) dated April 24, 2018, explicitly titled 'Aktietilbagekøb' (Share Buyback). It details the acquisition of 134,000 own shares by ChemoMetec A/S, bringing their total holding to 11.72% of the share capital. This action directly relates to the company purchasing its own stock, which corresponds precisely to the definition of 'Transaction in Own Shares' (Code: POS). The document length is very short (1322 chars), confirming it is an announcement rather than a comprehensive report.
2018-04-24 English
Earnings Release 2018
Earnings Release Classification · 99% confidence The document is a short announcement (1300 chars) titled 'MEDDELELSE NR. 148' (Announcement No. 148) dated April 4, 2018. The content explicitly states an 'Opjustering af omsætning og driftsresultat' (Upward adjustment of revenue and operating profit) for the fiscal year 2017/18, providing revised guidance figures (DKK 104-107 mio. revenue, DKK 23-26 mio. EBITDA). This is a classic example of an initial, brief announcement of key financial results or guidance changes, not the full detailed report. This fits the definition of an Earnings Release (ER). It is too specific for a general Regulatory Filing (RNS) and too brief/focused to be a comprehensive Interim Report (IR) or Annual Report (10-K). FY 2018
2018-04-04 English
Earnings Release 2018
Earnings Release Classification · 100% confidence The document is a short announcement (1783 characters) titled "Opjustering af omsætning og driftsresultat" (Adjustment of revenue and operating profit). It explicitly states updated financial guidance (revenue and EBITDA) for the fiscal year 2017/18, dated April 4, 2018. This content aligns perfectly with an Earnings Release (ER), which is the initial announcement of periodical financial results, often containing guidance updates before the full report is issued. It is too specific for a general Regulatory Filing (RNS) and is not a full report (10-K or IR). FY 2018
2018-04-04 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.